Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects
Authorized Users Only
2017
Authors
Vladimirov, Sandra
Gojković, Tamara

Spasojević-Kalimanovska, Vesna

Zeljković, Aleksandra

Vekić, Jelena

Kalimanovska-Oštrić, Dimitra
Jelić-Ivanović, Zorana

Conference object (Published version)

Metadata
Show full item recordSource:
Atherosclerosis, 2017, 263, e217-e217Publisher:
- Elsevier Ireland Ltd, Clare
Note:
- 85th Congress of the European-Atherosclerosis-Society (EAS), 2017.
DOI: 10.1016/j.atherosclerosis.2017.06.708
ISSN: 0021-9150
PubMed: 29365842
WoS: 000407634000671
[ Google Scholar ]Collections
Institution/Community
PharmacyTY - CONF AU - Vladimirov, Sandra AU - Gojković, Tamara AU - Spasojević-Kalimanovska, Vesna AU - Zeljković, Aleksandra AU - Vekić, Jelena AU - Kalimanovska-Oštrić, Dimitra AU - Jelić-Ivanović, Zorana PY - 2017 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2828 PB - Elsevier Ireland Ltd, Clare C3 - Atherosclerosis T1 - Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects VL - 263 SP - e217 EP - e217 DO - 10.1016/j.atherosclerosis.2017.06.708 ER -
@conference{ author = "Vladimirov, Sandra and Gojković, Tamara and Spasojević-Kalimanovska, Vesna and Zeljković, Aleksandra and Vekić, Jelena and Kalimanovska-Oštrić, Dimitra and Jelić-Ivanović, Zorana", year = "2017", publisher = "Elsevier Ireland Ltd, Clare", journal = "Atherosclerosis", title = "Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects", volume = "263", pages = "e217-e217", doi = "10.1016/j.atherosclerosis.2017.06.708" }
Vladimirov, S., Gojković, T., Spasojević-Kalimanovska, V., Zeljković, A., Vekić, J., Kalimanovska-Oštrić, D.,& Jelić-Ivanović, Z.. (2017). Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects. in Atherosclerosis Elsevier Ireland Ltd, Clare., 263, e217-e217. https://doi.org/10.1016/j.atherosclerosis.2017.06.708
Vladimirov S, Gojković T, Spasojević-Kalimanovska V, Zeljković A, Vekić J, Kalimanovska-Oštrić D, Jelić-Ivanović Z. Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects. in Atherosclerosis. 2017;263:e217-e217. doi:10.1016/j.atherosclerosis.2017.06.708 .
Vladimirov, Sandra, Gojković, Tamara, Spasojević-Kalimanovska, Vesna, Zeljković, Aleksandra, Vekić, Jelena, Kalimanovska-Oštrić, Dimitra, Jelić-Ivanović, Zorana, "Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects" in Atherosclerosis, 263 (2017):e217-e217, https://doi.org/10.1016/j.atherosclerosis.2017.06.708 . .